Blackrock, INC Schedule 13G passive stakes

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 5.0% beneficial ownership stake in Cipher Mining Inc.'s common stock as of March 31, 2025.

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a beneficial ownership of 0.9% in iShares Trust Common Stock as of March 31, 2025.

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 0.2% beneficial ownership stake in iShares Trust as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a passive beneficial ownership of 4.7% of Landsea Homes Corp's common stock as of March 31, 2025.

BlackRock, Inc. has filed an Amendment No. 6 to its Schedule 13G for iSHARES TRUST, reporting a 0.0% beneficial ownership stake as of March 31, 2025.

BlackRock, Inc. has filed an amendment to its Schedule 13G for iShares Trust, indicating it no longer holds a reportable beneficial ownership stake in the common stock as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G indicating it no longer holds a reportable beneficial ownership stake in Helix Acquisition Corp. II's Class A Stock, now owning 0%.

BlackRock, Inc. has filed an amended Schedule 13G, reporting zero beneficial ownership in the common stock of iShares Large Cap Max Buffer Jun ETF as of March 31, 2025.

BlackRock, Inc. has filed an Amendment No. 3 to Schedule 13G, reporting that its beneficial ownership in iShares Trust's Common Stock has decreased to 0% as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, indicating a 0% beneficial ownership stake in iShares Trust as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G for iShares Trust, reporting zero beneficial ownership of its common stock as of March 31, 2025.

BlackRock, Inc. has filed an amendment to its Schedule 13G, indicating it no longer holds a reportable beneficial ownership stake in iShares Trust as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, indicating that its beneficial ownership in iShares, Inc. common stock is 0% as of March 31, 2025.

BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting 0% beneficial ownership in iShares Trust as of March 31, 2025.

BlackRock, Inc. has filed an amendment to its Schedule 13G for iShares, Inc., indicating that its beneficial ownership of the common stock has fallen to 0% as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting zero beneficial ownership of iShares, Inc. Common Stock as of March 31, 2025.

BlackRock, Inc. has filed an amendment to its Schedule 13G, indicating it no longer holds a reportable beneficial ownership stake in iShares Trust.

BlackRock, Inc. has filed an Amendment No. 19 to its Schedule 13G for iShares Trust, indicating it no longer holds a reportable beneficial ownership stake in the entity as of March 31, 2025.

BlackRock, Inc. has filed an Amendment No. 16 to its Schedule 13G for iShares, Inc., reporting zero beneficial ownership in the common stock as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G indicating it no longer holds any beneficial ownership in Milestone Pharmaceuticals Inc., reducing its stake to 0.0%.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 10.6% beneficial ownership stake in Fidelity National Financial, Inc. as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, revealing a 14.7% beneficial ownership stake in Supernus Pharmaceuticals, Inc. as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 14.2% of American Assets Trust, Inc.'s common stock as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 10.4% of RLJ Lodging Trust's common stock as of March 31, 2025.

BlackRock, Inc. has filed an Amendment No. 9 to its Schedule 13G for BlackRock ETF Trust, reporting 0% beneficial ownership as of March 31, 2025.

BlackRock, Inc. has filed an Amendment No. 4 to Schedule 13G, reporting a 0.0% beneficial ownership stake in iSHARES TRUST Common Stock as of March 31, 2025.

BlackRock, Inc. has filed an amendment to its Schedule 13G, indicating it no longer holds a beneficial ownership stake in iShares Trust as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, indicating that its beneficial ownership in BlackRock ETF Trust II has fallen below the reporting threshold to 0%.

BlackRock, Inc. has filed an amended Schedule 13G, reporting zero beneficial ownership of Common Stock in iShares, Inc. (CUSIP 464286707), which appears to refer to the iShares MSCI France ETF, as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 2.1% beneficial ownership stake in iShares Core U.S. REIT ETF as of March 31, 2025, while noting that its subsidiary, BlackRock Japan Co., Ltd., holds over 5% of the class.